Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 418,761 | 391,918 | 434,925 | 402,062 | 415,605 |
| Cost of Goods | 199,017 | 174,936 | 214,060 | 195,071 | 206,273 |
| Gross Profit | 219,744 | 216,982 | 220,865 | 206,991 | 209,332 |
| Operating Expenses | 200,476 | 206,448 | 197,885 | 195,301 | 722,279 |
| Operating Income | 19,285 | 11,470 | 23,040 | 11,761 | -512,674 |
| Interest Expense | 22,994 | 22,465 | 23,673 | 22,725 | 21,042 |
| Other Income | 8,453 | 8,586 | 4,943 | 4,140 | 2,764 |
| Pre-tax Income | 4,744 | -2,409 | 4,310 | -6,824 | -530,952 |
| Income Tax | 262 | 2,208 | 6,014 | -1,420 | -46,879 |
| Net Income Continuous | 4,482 | -4,617 | -1,704 | -5,404 | -484,073 |
| Net Income | $4,482 | $-4,617 | $-1,704 | $-5,404 | $-484,073 |
| EPS Basic Total Ops | 0.06 | -0.06 | -0.03 | -0.07 | -6.31 |
| EPS Basic Continuous Ops | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 |
| EPS Diluted Total Ops | 0.06 | -0.06 | -0.03 | -0.07 | -6.31 |
| EPS Diluted Continuous Ops | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.54 | 0.83 | 0.54 | 0.45 |
| EBITDA(a) | $58,440 | $50,895 | $62,485 | $51,598 | $-473,092 |